216 related articles for article (PubMed ID: 32727595)
1. Evaluation of risk factors of vertebral fracture in Japanese female patients with glucocorticoid-induced osteoporosis.
Mori Y; Izumiyama T; Baba K; Mori N; Fujii H; Ishii T; Itoi E
J Orthop Surg Res; 2020 Jul; 15(1):290. PubMed ID: 32727595
[TBL] [Abstract][Full Text] [Related]
2. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
Kumagai S; Kawano S; Atsumi T; Inokuma S; Okada Y; Kanai Y; Kaburaki J; Kameda H; Suwa A; Hagiyama H; Hirohata S; Makino H; Hashimoto H
J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
[TBL] [Abstract][Full Text] [Related]
3. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
[TBL] [Abstract][Full Text] [Related]
4. Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.
Florez H; Hernández-Rodríguez J; Muxi A; Carrasco JL; Prieto-González S; Cid MC; Espinosa G; Gómez-Puerta JA; Monegal A; Guañabens N; Peris P
Rheumatology (Oxford); 2020 Jul; 59(7):1574-1580. PubMed ID: 31628810
[TBL] [Abstract][Full Text] [Related]
5. Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database.
Adami G; Gatti D; Rossini M; Giollo A; Gatti M; Bertoldo F; Bertoldo E; Mudano AS; Saag KG; Viapiana O; Fassio A
Bone; 2024 Feb; 179():116958. PubMed ID: 37949390
[TBL] [Abstract][Full Text] [Related]
6. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.
LeBlanc CM; Ma J; Taljaard M; Roth J; Scuccimarri R; Miettunen P; Lang B; Huber AM; Houghton K; Jaremko JL; Ho J; Shenouda N; Matzinger MA; Lentle B; Stein R; Sbrocchi AM; Oen K; Rodd C; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Rauch F; Siminoski K; Ward LM;
J Bone Miner Res; 2015 Sep; 30(9):1667-75. PubMed ID: 25801315
[TBL] [Abstract][Full Text] [Related]
7. Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders.
Ward LM; Ma J; Robinson ME; Scharke M; Ho J; Houghton K; Huber A; Scuccimarri R; Barsalou J; Roth J; Shenouda N; Matzinger MA; Lentle B; Jaremko JL; Koujok K; Watanabe Duffy K; Stein R; Sbrocchi AM; Rodd C; Miettunen PM; LeBlanc CMA; Larche M; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Sykes E; Konji VN; Rauch F; Siminoski K; Lang B
J Clin Endocrinol Metab; 2021 Nov; 106(12):e5195-e5207. PubMed ID: 34232311
[TBL] [Abstract][Full Text] [Related]
8. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial.
Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T
Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824
[TBL] [Abstract][Full Text] [Related]
9. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
Rehman Q; Lang T; Modin G; Lane NE
Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.
Angeli A; Guglielmi G; Dovio A; Capelli G; de Feo D; Giannini S; Giorgino R; Moro L; Giustina A
Bone; 2006 Aug; 39(2):253-9. PubMed ID: 16574519
[TBL] [Abstract][Full Text] [Related]
11. Impact of Bone Mineral Density on the Incidence of Age-Related Vertebral Fragility Fracture.
Lee J; Chang G; Kang H; Ham DW; Lee JS; Jung HS; Song KS
J Korean Med Sci; 2020 May; 35(17):e116. PubMed ID: 32356418
[TBL] [Abstract][Full Text] [Related]
12. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain.
Yi Y; Hwang B; Son H; Cheong I
Pain Physician; 2012; 15(6):441-9. PubMed ID: 23159959
[TBL] [Abstract][Full Text] [Related]
13. Determinants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii.
Huang C; Ross PD; Fujiwara S; Davis JW; Epstein RS; Kodama K; Wasnich RD
Bone; 1996 May; 18(5):437-42. PubMed ID: 8739901
[TBL] [Abstract][Full Text] [Related]
14. Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses.
Florez H; Hernández-Rodríguez J; Carrasco JL; Prieto-González S; Muxi A; Filella X; Ruiz-Gaspà S; Gómez-Puerta JA; Cid M; Espinosa G; Monegal A; Guañabens N; Peris P
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917834
[TBL] [Abstract][Full Text] [Related]
15. Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid Treatment.
Shen J; Griffith JF; Zhu TY; Tang P; Kun EW; Lee VK; Yip RM; Kwok KY; Ying SK; Ho CT; Lau SL; Pui MO; Li TK; Lau EY; Lee JJ; Qin L; Tam LS
J Clin Endocrinol Metab; 2018 Sep; 103(9):3340-3349. PubMed ID: 29982545
[TBL] [Abstract][Full Text] [Related]
16. Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid.
Lee KA; Kim J; Kim HJ; Kim HS
Int J Rheum Dis; 2021 Aug; 24(8):1053-1060. PubMed ID: 34184827
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
Okubo N; Matsui S; Matsumoto T; Sugimoto T; Hosoi T; Osakabe T; Watanabe K; Takami H; Shiraki M; Nakamura T
Calcif Tissue Int; 2020 Dec; 107(6):559-566. PubMed ID: 32839843
[TBL] [Abstract][Full Text] [Related]
18. Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study.
Inoue Y; Mitsunaga K; Yamamoto T; Chiba K; Yamaide F; Nakano T; Morita Y; Yamaide A; Suzuki S; Arima T; Yamaguchi KI; Tomiita M; Shimojo N; Kohno Y
Pediatr Rheumatol Online J; 2018 Jun; 16(1):36. PubMed ID: 29914510
[TBL] [Abstract][Full Text] [Related]
19. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
Soen S
Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials.
Liu Z; Zhang M; Shen Z; Ke J; Zhang D; Yin F
PLoS One; 2020; 15(12):e0243851. PubMed ID: 33326444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
